Brainsway Profit Margin

The latest profit margin for BRSYF is 15.61% as of March 2026. That compares with 9.01% in the prior-year period — up 73.1% year over year. That is above the Healthcare sector average of 15.29%. Investors often review this figure alongside Brainsway's historical trend and sector peers before judging valuation or financial health.

Over the past year, BRSYF's profit margin moved from 9.01% to 15.61% — a 73.1% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Brainsway's valuation or profitability profile.

Against Healthcare companies, BRSYF currently prints 15.61% for profit margin, while the sector average sits near 15.29%. That is roughly 2.0% above the sector mean. Large gaps often invite a closer look at Brainsway's growth, margins, and balance sheet.

Profit Margin shows how effectively Brainsway converts resources into returns. At 15.61%, BRSYF may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 9.01% in the prior-year period — up 73.1% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting BRSYF's profit margin (15.61%), review year-over-year change from 9.01%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.